NCT02702648View on ClinicalTrials.gov

First-in-man Study of Single and Multiple Ascending Doses of a New Drug for Neurological Disorders

PHASE1CompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

February 1, 2016

Primary Completion Date

March 6, 2017

Study Completion Date

March 6, 2017

Conditions
Healthy Subjects
Interventions
DRUG

AC-082

Hard gelatin capsules for oral administration

DRUG

Placebo

Matched placebo capsules for oral administration

Trial Locations (1)

14050

Investigator Site, Berlin

Sponsors
All Listed Sponsors
lead

Idorsia Pharmaceuticals Ltd.

INDUSTRY

NCT02702648 - First-in-man Study of Single and Multiple Ascending Doses of a New Drug for Neurological Disorders | Biotech Hunter | Biotech Hunter